Comparison Neuromuscular Blockade Monitors - Trial NCT05006807
Access comprehensive clinical trial information for NCT05006807 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Washington and is currently Recruiting. The study focuses on Neuromuscular Blockade. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Washington
Timeline & Enrollment
N/A
Feb 01, 2022
Jun 30, 2024
Primary Outcome
Train-of-four count,Train-of-four ratio,Post tetanic count,Twitch count by palpation
Summary
The overall objective of this research is to evaluate different laboratory-built and
 commercially available sensors used to measure the effects of neuromuscular blocking drugs on
 neuromuscular function during surgery, by measuring evoked thumb twitch response to ulnar
 nerve stimulation (also known as twitch monitoring). The specific aim is to compare
 mechanomyography, which is the gold standard laboratory measurement to assess neuromuscular
 blockade, to the sensors used in commercially available neuromuscular blockade monitors, such
 as acceleromyography and electromyography. The study endpoints are the train-of-four count
 (TOFC), the ratio of the height of the 4th twitch to the height of the 1st twitch
 (train-of-four ratio, TOFR), and the post tetanic count (PTC). The mechanomyography devices
 have been constructed in our laboratory and are not commercially available.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05006807
Device Trial